Literature DB >> 17406204

Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression.

Pratip K Chattopadhyay1, Joanne Yu, Mario Roederer.   

Abstract

This protocol details a method to identify CD4+ T cells that respond to antigens. The method relies on detection of CD154, a costimulatory cell surface protein that is expressed by CD4+ T cells upon activation, and can be used to purify live CD4+ T cells of diverse function. To detect CD154, fluorescently labeled antibodies are cultured with cell samples, peptides (or whole antigens) and monensin during a 6- to 24-h stimulation period. (Note that the assay is not compatible with brefeldin A.) After stimulation, cells are stained with any other antibodies of interest and then are analyzed by flow cytometry or purified by cell sorting. Unlike other assays, this method allows simultaneous assessment of other cell phenotypes or functions, is compatible with downstream RNA-based assays and preserves cell viability. This protocol can be completed in 9 h.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406204     DOI: 10.1038/nprot.2006.1

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  67 in total

1.  Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

Authors:  Judith H Aberle; Karin Stiasny; Michael Kundi; Franz X Heinz
Journal:  Age (Dordr)       Date:  2012-01-27

2.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

3.  Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  OMIP-025: evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining.

Authors:  Gemma Moncunill; Carlota Dobaño; M Juliana McElrath; Stephen C De Rosa
Journal:  Cytometry A       Date:  2014-11-18       Impact factor: 4.355

5.  Flow Cytometric Characterization of Human Antigen-Reactive T-Helper Cells.

Authors:  Carina Saggau; Alexander Scheffold; Petra Bacher
Journal:  Methods Mol Biol       Date:  2021

6.  Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood.

Authors:  Hanchih Wu; Ashley Witzl; Hideki Ueno
Journal:  Blood Adv       Date:  2019-07-23

7.  Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.

Authors:  Simon Turcotte; Alena Gros; Katherine Hogan; Eric Tran; Christian S Hinrichs; John R Wunderlich; Mark E Dudley; Steven A Rosenberg
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

Review 8.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  CD40 promotes MHC class II expression on adipose tissue macrophages and regulates adipose tissue CD4+ T cells with obesity.

Authors:  David L Morris; Kelsie E Oatmen; Taleen A Mergian; Kae Won Cho; Jennifer L DelProposto; Kanakadurga Singer; Carmella Evans-Molina; Robert W O'Rourke; Carey N Lumeng
Journal:  J Leukoc Biol       Date:  2015-12-11       Impact factor: 4.962

10.  CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.

Authors:  Brian Kavanagh; Shaun O'Brien; David Lee; Yafei Hou; Vivian Weinberg; Brian Rini; James P Allison; Eric J Small; Lawrence Fong
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.